成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

武漢敬康恩生物醫(yī)藥科技有限公司 Company Information
Company Name:    Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:    13720134139 +86 -0-15871494362
Email:    orders@jknbiochem.com
Nationality:    China
WebSite:    www.jknbiochem.com
Product List:    5821
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Product List
Sulesomab 167747-19-5
Research Grade Cc49
Motavizumab 677010-34-3
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate 161797-99-5
Olaparib 763113-22-0
Eculizumab 219685-50-4
Hu1D10 267227-08-7
Natalizumab 189261-10-7
Capromab 145464-28-4
palivizumab 188039-54-5
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate 161798-03-4
Ethyl 2-(3-formyl-4- hydroxyphenyl)-4- methylthiazole-5-carboxylate 161798-01-2
Ranibizumab 347396-82-1
Basiliximab 179045-86-4
Ibrutinib (PCI-32765) 936563-96-1
ApreMilast 608141-41-9
Lambrolizumab 1374853-91-4
4-hydroxythiobenzamide 25984-63-8
Iodine (131I) Derlotuximab Biotin 340013-96-9
Omalizumab 242138-07-4
Lorvotuzumab Mertansine 1008106-64-6
Enlimomab 142864-19-5
Edobacomab 141410-98-2
NEW PRODUCTS INTRODUCTION
mepolizumab 196078-29-2
Foravirumab 944548-38-3
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate 160844-75-7
Diisopropylamine dichloroacetate 660-27-5
Pascolizumab 331243-22-2
Siplizumab 288392-69-8
Ruplizumab 220651-94-5
Visilizumab 219716-33-3
Vonoprazan 881681-00-1
Research Grade Fontolizumab 326859-36-3
Ixekizumab 1143503-69-8
dupilumab 1190264-60-8
(S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione 189028-93-1
Narsoplimab 2108782-45-0
Neratinib 688387-09-6
Nofetumomab 165942-79-0
Igovomab 171656-50-1
Research Grade Immurait-Ll2Mab
Research Grade Tecnemab
Pexelizumab 219685-93-5
4,4-dimethyl-3,5,8- trioxabicyclo[5.1.0]octane 57280-22-5
Pomalidomide 19171-19-8
Topiroxostat 577778-58-6
TocilizuMab 375823-41-9
Bevacizumab 216974-75-3
Dacliximab 152923-56-3
Imciromab 126132-83-0
Research Grade Afelimomab 156227-98-4
Arcitumomab 154361-48-5
Pertuzumab 380610-27-5
Matuzumab 339186-68-4
Carbazochrome Sodium Sulfonate 51460-26-5
nimotuzumab 828933-51-3
Crisaborole 906673-24-3
Nivolumab 946414-94-4
Sarilumab 1189541-98-7
1-Methylcyclopropanecarboxylic acid 6914-76-7
Amatuximab 931402-35-6
Febuxostat 144060-53-7
Bavituximab 648904-28-3
Abciximab 143653-53-6
Biciromab 138783-13-8
Rafivirumab 944548-37-2
Research Grade Cedelizumab 156586-90-2
Gemtuzumab 220578-59-6
Satumomab 144058-40-2
Sevirumab
Research Grade cT84.66
(R)-(-)-2,2-dimethyl-1,3-dioxolane-4-methanol 14347-78-5
Lymphocide 205923-57-5
Milatuzumab 899796-83-9
Odulimomab 159445-64-4
(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one 189028-95-3
Abemaciclib 1231929-97-7
EFALIZUMABUM 214745-43-4
Mitumomab 216503-58-1
Labetuzumab 219649-07-7
Ezetimibe 163222-33-1
Inolimomab 152981-31-2
Edrecolomab 156586-89-9
Lintuzumab 166089-32-3
Naptumomab Estafenatox 676258-98-3
Tadocizumab 339086-80-5
Abagovomab 792921-10-9
Alemtuzumab 216503-57-0
Research Grade T10B9.1A-31
Tositumomab 208921-02-2
cantuzumab mertansine 400010-39-1
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate 161798-02-3
Gevokizumab 1129435-60-4
Apalutamide 956104-40-8
Oregovomab 213327-37-8
Erlotinib Hydrochloride 183321-74-6
Gavilimomab 244096-20-6
Siltuximab 541502-14-1
Entecavir hydrate 209216-23-9
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2007©  ChemicalBook. All rights reserved.